RxDoctor Payments DataLook up a doctor →

Scott Satko, MD

Nephrology · Winston Salem, NCNPI 1962487397

Payments from drug & device makers

$95,027in general payments, 2019–2025

Across 475 payments — averaging $200.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$58K
  • Bayer$30K
  • Amgen$941
  • Otsuka America Pharmaceutical, Inc.$756
  • Vifor Pharma, Inc.$541
  • Novartis$443
  • plus $5K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)86$57,704
Bayer25$30,045
Amgen(2 entities)47$941
Otsuka America Pharmaceutical, Inc.35$756
Vifor Pharma, Inc.25$541
Novartis27$443
Aurinia Pharma U.S., Inc.15$404
Mallinckrodt Hospital Products Inc.18$402
ANI Pharmaceuticals, Inc.23$401
Travere Therapeutics, Inc.19$380
Akebia Therapeutics Inc21$351
GSK16$343
Mallinckrodt Enterprises LLC11$299
Boehringer Ingelheim16$281
OPKO Pharmaceuticals, LLC12$202
Novo Nordisk11$191
Takeda Pharmaceuticals U.S.A., Inc.8$185
Calliditas Therapeutics US Inc.9$177
Fresenius USA Marketing, Inc.9$154
Daiichi Sankyo Inc.6$130
Otsuka Pharmaceutical Development & Commercialization, Inc.1$99
Shield Therapeutics Inc5$80
Lilly USA, LLC4$65
Ardelyx, Inc.3$53
Apellis Pharmaceuticals, Inc.3$51
Scpharmaceuticals Inc.2$42
Kyowa Kirin, Inc.2$38
Argenx US, Inc.2$38
Arbor Pharmaceuticals, Inc.2$31
Shire North American Group Inc2$26
Outset Medical Inc1$24
Baxter Healthcare1$22
Cycle Pharmaceuticals Inc1$20
Teleflex LLC1$19
Genentech USA, Inc.1$18
Cormedix Inc.1$17
Bard Peripheral Vascular, Inc.1$16
Biomerieux Inc1$15
Johnson & Johnson1$12
AMAG Pharmaceuticals, Inc.1$11

How this compares

$95,027 in reported general payments places this provider in the 85th percentile of 366 nephrology providers in North Carolina.

See all nephrology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$160,979
Medicare patients
439
Services billed
1,338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Winston Salem

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →